Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study

LESSON LEARNED. Circulating tumor cells, microRNA markers, or other biomarkers merit examination as part of correlative scientific analyses in prospective clinical trials. BACKGROUND. Platinum chemotherapy resistance occurs in approximately 25% of patients with ovarian carcinoma; however, no biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Emil, Vogel, Rachel I., Hoostal, Spencer, Wong, Phillip, Grad, Aaron, Monu, Minnu, Łukaszewski, Tomasz, Deshpande, Jaai, Dickson, Elizabeth L., Klein, Molly, Linden, Michael A., Subramanian, Subbaya, Teoh, Deanna, Geller, Melissa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853113/
https://www.ncbi.nlm.nih.gov/pubmed/31346130
http://dx.doi.org/10.1634/theoncologist.2019-0497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853113/
https://www.ncbi.nlm.nih.gov/pubmed/31346130
http://dx.doi.org/10.1634/theoncologist.2019-0497

Ejemplares similares